DOI QR코드

DOI QR Code

오가피청혈플러스가 NF-κB 및 MAPKs 신호전달체계와 혈관부착인자 등에 미치는 영향

The Effect of Acanthopanax sessiliflorum Cheonghyeol Plus on NF-κB and MAPKs Signaling and Vascular Attachment Factors

  • 이지원 (대전자생한방병원 한방내과) ;
  • 최규철 (대전자생한방병원 한방내과) ;
  • 배지은 (대전자생한방병원 한방내과) ;
  • 유호룡 (대전대학교 한의과대학 심계내과학교실) ;
  • 김윤식 (대전대학교 한의과대학 심계내과학교실) ;
  • 설인찬 (대전대학교 한의과대학 심계내과학교실)
  • Lee, Ji-won (Dept. of Korean Internal Medicine, Dae-Jeon Jaseng Hospital of Korean Medicine) ;
  • Choi, Gyu-cheol (Dept. of Korean Internal Medicine, Dae-Jeon Jaseng Hospital of Korean Medicine) ;
  • Bae, Ji-eun (Dept. of Korean Internal Medicine, Dae-Jeon Jaseng Hospital of Korean Medicine) ;
  • Yoo, Ho-ryong (Dept. of Cardiology and Neurology of Korean Medicine, College of Korean Medicine, Dae-Jeon University) ;
  • Kim, Yoon-sik (Dept. of Cardiology and Neurology of Korean Medicine, College of Korean Medicine, Dae-Jeon University) ;
  • Seol, In-chan (Dept. of Cardiology and Neurology of Korean Medicine, College of Korean Medicine, Dae-Jeon University)
  • 투고 : 2020.12.01
  • 심사 : 2020.12.31
  • 발행 : 2020.12.30

초록

Objective: This study was performed to investigate the effect of Acanthopanax sessiliflorum Cheonghyeol plus (ASCP) on NF-κB and MAPK signaling and vascular adhesion factors associated with dyslipidemia in human umbilical vein endothelial cells (HUVECs). Methods: We measured the scavenging activity of DPPH radical and ABTS radical by ASCP in HUVECs. We measured the protein expression levels of NF-κB, IκBα, ERK, JNK, and p38 after treatment of HUVECs with TNF-α. We measured the expression levels of MCP-1, ICAM-1, and VCAM-1 mRNA and of MCP-1, ICAM-1, and VCAM-1 biomarkers after treatment of HUVECs with TNF-α. Results: The DPPH and ABTS radical scavenging activity of ASCP increased in a concentration-dependent manner. NF-κB, IκB, ERK, p38 protein expression levels decreased following ASCP treatment at all concentrations compared to untreated control HUVECs. JNK protein expression levels decreased in ASCP-treated HUVECs compared to untreated controls at concentrations of 100 ㎍/mL. MCP-1 mRNA expression level decreased with ASCP treatment ≥200 ㎍/mL compared to the control. ICAM-1 and VCAM-1 mRNA expression levels decreased at all concentrations compared to the control. MCP-1 protein expression level was reduced compared to the control at concentrations ≥200 ㎍/mL, ICAM-1 protein expression level was reduced compared to the control at concentrations ≥100 ㎍/mL, and VCAM-1 protein expression level was reduced at all concentrations. Conclusions: These results suggest that ASCP has an antioxidative and hypolipidemic effect and that ASCP could treat and prevent dyslipidemia, atherosclerosis, and cardio-cerebrovascular diseases.

키워드

참고문헌

  1. Kim TH, Son YK, Hwang KH, Kim MH. Effects of Angelica keiskei Koidzumi and Turmeric Extract Supplementation on Serum Lipid Parameters in Hypercholesterolemic Diet or P-407-Induced Hyperlipidemic Rats. J Korean Soc Food Sci Nutr 2008;37(6):708-13. https://doi.org/10.3746/JKFN.2008.37.6.708
  2. Koh KK, Quon MJ, Rosenson RS, Chung WJ, Han SH. Vascular and metabolic effects of treatment of combined hyperlipidemia: Focus on statins and fibrates. International Journal of Cardiology 2008;124(2):149-59. https://doi.org/10.1016/j.ijcard.2007.04.080
  3. Korean society of lipidology and atherosclerosis. Guidelines for the management of dyslipidemia. Seoul: Korean society of lipidology and atherosclerosis; 2015.
  4. Crandall JP, Mather K, Rajpathak SN, Goldberg RB, Watson K, Foo S, et al. Statin use and risk of developing diabetes:results from the diabetes prevention program. BMJ Open Daib Res Care 2017;5(1):1-8.
  5. Jung UY, Ahn KS. Korean Medicine Clinicopathology. Seoul: Younglim publisher; 1998, p. 545.
  6. Hasani-Ranjbar S, Nayebi N, Moradi L, Mehri A, Larijani B, Abdollahi M. The efficacy and safety of herbal medicines used in the treatment of hyperlipidemia; a systematic review. Current pharmaceutical design 2010;16(26):2935-47. https://doi.org/10.2174/138161210793176464
  7. Dinani NJ, Asgary A, Madani H, Naderi GH, Mahzoni P. Hypocholesterolemic and antiathero sclerotic effect of artemisia aucheri in hypercholesterolemic rabbits. Pakistan Journal of Pharmaceutical Sciences 2010;23(3):321-5.
  8. Dou XB, Wo XD, Fan CL. Progress of research in treatment of hyperlipidemia by monomer or compound recipe of Chinese herbal medicine. Chinese Journal of Integrative Medicine 2008;14(1):71-5. https://doi.org/10.1007/s11655-008-0071-y
  9. Singh BB, Vinjamury SP, Der-Martirosian C, Kubik E, Mishra LC, Shepard NP, et al. Ayurvedic and collateral herbal treatments for hyperlipidemia: a systematic review of randomized controlled trials and quasi-experimental designs. Alternative therapies in health and medicine 2007;13(4):22-8.
  10. Hong YK, Kim SS, Shin MK, Kim JJ. Review of Korean Medical Treatment in Hyperlipidemia - focusing on treatment of Korean herbal medicine. J Physiol & Pathol Korean Med 2010;24(1):9-14.
  11. Rouhi-Boroujeni H, Rouhi-Boroujeni H, Heidarian E, Mohammadizadeh F, Rafieian-Kopaei M. Herbs with anti-lipid effects and their interactions with statins as a chemical anti-hyperlipidemia group drugs: A systematic review. ARYA atherosclerosis 2015;11(4):244-51.
  12. Guo J, Bei W, Hu Y, Tang C, He W, Liu X, et al. A new TCM formula FTZ lowers serum cholesterol by regulating HMG-CoA reductase and CYP7A1 in hyperlipidemic rats. Journal of ethnopharmacology 2011;135(2):299-307. https://doi.org/10.1016/j.jep.2011.03.012
  13. Liu ZL, Liu JP, Zhang AL, Wu Q, Ruan Y, Lewith G, et al. Chinese herbal medicines for hypercholesterolemia. The Cochrane Library 2011 Jul:1-62.
  14. Guo M, Liu Y, Gao ZY, Shi DZ. Chinese herbal medicine on dyslipidemia: progress and perspective. Evidence-Based Complementary and Alternative Medicine 2014;2014:163036. https://doi.org/10.1155/2014/163036
  15. Gao Q, Qin WS, Jia ZH, Zheng JM, Zeng CH, Li LS, et al. Rhein improves renal lesion and ameliorates dyslipidemia in db/db mice with diabetic nephropathy. Planta Medica 2010;76(1):27-33. https://doi.org/10.1055/s-0029-1185948
  16. Du J, Sun LN, Xing WW, Huang BK, Jia M, Wu JZ, et al. Lipid-lowering effects of polydatin from Polygonum cuspidatum in hyperlipidemic hamsters. Phytomedicine 2009;16(6-7):652-8. https://doi.org/10.1016/j.phymed.2008.10.001
  17. Chang XX, Yan HM, Xu Q, Xia MF, Bian H, Zhu TF, et al. The effects of berberine on hyperhomocysteinemia and hyperlipidemia in rats fed with a long-term high-fat diet. Lipids in Health and Disease 2012;11:86. https://doi.org/10.1186/1476-511X-11-86
  18. Kwok CY, Li C, Cheng HL, Ng YF, Chan TY, Kwan YW, et al. Cholesterol lowering and vascular protective effects of ethanolic extract of dried fruit of Crataegus pinnatifida, hawthorn (Shan Zha), in diet-induced hypercholesterolaemic rat model. Journal of Functional Foods 2013;5(3):1326-35. https://doi.org/10.1016/j.jff.2013.04.020
  19. Jung ES, Kim HT, Choi KE, Oh JM, Cho HK, Yoo HR, et al. A Case Report of the Beneficial Effects of Chunghyul-Plus in Dyslipidemia Patients. Korean Journal of Stroke 2016;17(1):55-66.
  20. Congkun X, Rui W, Zhifang Y. Study on effect of Polygonum mutiflorum extract on lipid metabolism and its anti-oxidation in SD rats with hyperlipemia. China Pharmaceuticals 2009;18(24):19-20.
  21. Kim HT, Kim YS, Seol IC, Yoo HR. The Effects of an Extract of Artemisiae Capillaris, Curcumae Longae, and Crataegi Fructus(IUS) on Antihyperlipidemia and Anti-oxidation in db/db Mouse Model. The Journal of Internal Korean Medicine 2016;37(3):467-83.
  22. Choi KE, Seol IC, Kim YS, Cho HK, Yoo HR. Hypolipidemic and Anti-oxidant Effects of Chunghyl Plus in Type II Diabetic Mice Model. J Physiol & Pathol Korean Med 2016;30(3):164-76. https://doi.org/10.15188/kjopp.2016.06.30.3.164
  23. Kim TY, Oh JM, Kim YS, Jo HK, Yoo HR, Seol IC. Anti-dyslipidemic Effect of ACLL extract(Artemisia capillaris Thunb, Curcuma longa L, Lycium chinense, Ligustrum lucidum Aiton complex extract) on High Cholesterol Diet-induced Dyslipidemia in Mice. Daejeon university Korean medical institute 2016;25(1):133-44.
  24. Ryu JY, Cho HK, Yoo HR, Seol IC, Kim YS The Effects of Artemisiae Iwayomogii Herba, Curcumae Radix, and Aurantii Fructus Immaturus Complex Extract (ACA) on Dyslipidemia-related Factor Expression and Anti-oxidation in HepG2 Cells. The Journal of Internal Korean Medicine 2017;38(3):367-75. https://doi.org/10.22246/jikm.2017.38.3.367
  25. Cha JY, Yoo HR, Kim YS, Seol IC, Jo HK. Inhibition of gene associated with Dyslipidemia and Antioxidative Effect of Artemisia iwayomogi, Curcumae Radix and Raphani Semen and (ACR) on HepG2 cell model. Journal of Korean Medicine 2017;38(3):43-58. https://doi.org/10.13048/jkm.17024
  26. Park YS. Antioxidant Effects and Improvement of Lipid Metabolism of Acanthopanacis cortex Water Extract in Rats Fed High Fat Diet. Journal of The East Asian Society of Dietary Life 2010 Feb:37-45.
  27. Seo DH, Joo IH, Kim DH. Effect of ChungHuyl -Plus on inflammatory factors in Human Umbilical Vein Endothelial Cells (HUVECs). Journal of Haehwa Medicine 2018;27(2):11-20.
  28. Kim HT. Anti-oxidative and Anti-dyslipidemic Effects of the ChunghyulPlus(CHP) in HepG2 cells and Rats Induced Dyslipidemia by High Cholesterol diet. Daejeon University Graduate School Doctoral Thesis 2018.
  29. Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Heart Disease and Stroke Statistics-2017 Update: A Report From the Americaan Heart Association. Circulation 2017;135(10):e146-e603.
  30. Ministry of Health and Welfare, Korea Centers for Disease Control and Prevention. Korea Health Statistics 2015. Korea National Health and Nutrition Examination Survey (KNHANES VI-3). Available from https://knhanes.cdc.go.kr. Accessed October 1, 2017.
  31. Korean statistical information service. Korean Cause of Death Statistics 2019: Korean Death Rate Trend by Cause of Death. Available from: http://www.index.go.kr. Accessed September 25, 2020.
  32. Bang HJ, Tack ES, Hong Y, Kang YH. A Study of Hyperlipidemia by the theory of Traditional Korean Medicine. East-west medicine 1995;20(1):25-36.
  33. National Oriental Medical Department of herbology. Herbology. Seoul: Younglim-sa; 1994, p. 369-70, 411-2, 452-3, 458-9. 2010, p. 369-70, 392-3, 452-3.
  34. Kim MS, Chun SS, Choi JH. Effects of Turmeric (Curcuma longa L.) on Antioxidative Systems and Oxidative Damage in Rats Fed a High Fat and Cholesterol Diet. J Korean Soc Food Sci Nutr 2013;42(4):570-6. https://doi.org/10.3746/JKFN.2013.42.4.570
  35. Seong JH, Kim MA, Duan Y, Kim HS, Lee YG, Kim DS. Effects of Feral Haw(Crataegus pinnatifida Bunge) on Hepatic Functional Enzyme Activity in Dyslipidemic Rats. J East Asian Soc Dietary Life 2014;24(2):176-82.
  36. Go BS. The encyclopedia of Chinese Herbal medicine. 2nd edition. Daebukseong: Shinmoonpung; 1974, p. 216, 303-4, 1604, 2639.
  37. Kim JC. Sim Integrated Internal Science Understood by Anatomy and Pathogenesis. Cardiology. Seoul: JungDam; 2013, p. 205-8.
  38. Swerlick RA, Lawley TJ. Role of microvascular endothelial cells in inflammation. J Invest Dermatol 1993;100(1):S111-S115. https://doi.org/10.1038/jid.1993.33
  39. Wei CC, Yu CW, Yen PL, Lin HY, Chang ST, Hsu FL, et al. Antioxidant activity, delayed aging, and reduced amyloid-β toxicity of methanol extracts of tea seed pomace from Camellia tenuifolia. J Agric Food Chem 2014;62(44):10701-7. https://doi.org/10.1021/jf503192x
  40. Choi YM, Kim MH, Shin JJ, Park JM, Lee JS. The antioxidant activities of the some commercial teas. J Kor Soc Nutr 2003;32(5):723-7. https://doi.org/10.3746/jkfn.2003.32.5.723
  41. Yun HY, Dawson VL, Dawson TM. Neurobiology of nitric oxide. Crit Rev Neurobiol 1996;10(3-4):291-316. https://doi.org/10.1615/critrevneurobiol.v10.i3-4.20
  42. Sheller JR, Polosukhin VV, Mitchell D, Cheng DS, Peebles RS, Blackwell TS. Nuclear factor kappa B induction in airway epithelium increases lung inflammation in allergen-challenged mice. Exp Lung Res 2009;35(10):883-95. doi: 10.3109/01902140903019710.
  43. Schuliga M. NF-kappaB signaling in chronic inflammatory airway disease. Biomolecules 2015; 5(3):1266-83. doi: 10.3390/biom5031266.
  44. Chae SW. Function and Activation of NF-κB in Immune System. Korean J Otolaryngol 2005;48(3):284-8.
  45. Song HY, Lee JA, Ju SM, Yoo KY, Won MH, Kwon HJ, et al. Topical transduction of superoxide dismutase mediated by HIV-1T at protein transduction domain ameliorates 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced inflammation in mice. Biochem Pharmacol 2008;75(6):1348-57. https://doi.org/10.1016/j.bcp.2007.11.015
  46. Christopherson K, Hromas R. Chemokine Regulation of Normal and Pathologic Immune Responses. Stem Cells 2001;19(5):388-96. https://doi.org/10.1634/stemcells.19-5-388
  47. Rothlein R, Mainolfi EA, Czajkowski M, Marlin SD. A form of citculating ICAM-1 in human serum. J Immunol 1991;147(11):3788-93.
  48. Seth R, Raymond FD, Makgoba MW. Circulating ICAM-1 isoforms: diagnostic prospects for inflammatory and immune disorders. Journal of The Lancet 1991;338(8759):83-4. https://doi.org/10.1016/0140-6736(91)90077-3
  49. Osborn L, Hession C, Trizard R, Vassallo C, Luhowskyj S, Chi-Rosso G, et al. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell 1989;59(6):1203-11. https://doi.org/10.1016/0092-8674(89)90775-7
  50. Baran D, Vendeville B, Ogborn M, Katz N. Cell adhesion molecule expression in murine lupuslike nephritis induced by lipopolysaccharide. Nephron 2000;84(2):167-76. https://doi.org/10.1159/000045565